Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
the bull case· 4
10
customers naming the company as a supplier in their own filings
sec filingsfrom their filings10
disclosed supplier and customer ties recorded in SEC filings
sec filingsedgar5
funds on file reporting a position in the company
n-portas of Jun 30 '26+5.75%
change in shares held by the ten largest reporting managers last quarter
13fJun 30 '26the bear case· 3
12 of 21
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '261.20%
share of ARK Innovation ETF assets representing the largest fund weight on file
n-portApr 30 '2658
managers whose positions together make up four fifths of the reported value
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Oct 29 '26 report. Not a forecast, not advice.
Of the 6 companies Illumina, Inc. moves with most closely, 3 also share its SEC classification.
Measured against 499 trading days of our own closes. Co-movement, not cause.
SIC 3826, Laboratory Analytical Instruments, from each company's own filings. Largest first.
A rule beside a ticker marks a company that appears in both readings.
Which of these the filings never mention ›tall tick = annual report · 1 on record
938 managers report a position worth $27.6B between them, and 58 of them hold 80% of it.
ILMN (Illumina, Inc.) has 0 disclosed suppliers and 10 disclosed customers, strongest disclosure first.
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
High 234.86 at 9:30 am ET, low 222.50 at 5:45 am ET.
Illumina, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Laboratory Analytical Instruments